What is Ypsomed Holding AG Price-to-Free-Cash-Flow?
As of today (2024-05-12), Ypsomed Holding AG's share price is €120.372.
Ypsomed Holding AG's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was €-3.19. Hence, Ypsomed Holding AG's Price-to-Free-Cash-Flow Ratio for today is N/A.
The historical rank and industry rank for Ypsomed Holding AG's Price-to-Free-Cash-Flow or its related term are showing as below:
During the past 13 years, Ypsomed Holding AG's highest Price-to-Free-Cash-Flow Ratio was 172.49. The lowest was 43.97. And the median was 76.41.
FRA:OWX's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 34.64 * Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 18.80% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was -8.70% per year.
During the past 13 years, Ypsomed Holding AG's highest 3-Year average Free Cash Flow per Share Growth Rate was 58.70% per year. The lowest was -59.10% per year. And the median was -1.00% per year.
Ypsomed Holding AG Price-to-Free-Cash-Flow Historical Data
The historical data trend for Ypsomed Holding AG's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Ypsomed Holding AG's Price-to-Free-Cash-Flow
For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ypsomed Holding AG's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Ypsomed Holding AG's Price-to-Free-Cash-Flow falls into.
Ypsomed Holding AG Price-to-Free-Cash-Flow Calculation
Ypsomed Holding AG's Price-to-Free-Cash-Flow ratio for today is calculated as
Ypsomed Holding AG's Share Price of today is €120.372.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ypsomed Holding AG's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was €-3.19.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Ypsomed Holding AG (FRA:OWX) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Ypsomed Holding AG Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Ypsomed Holding AG's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company's sales, respectively.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:OWX has been successfully added to your 